Christopher D. Ma & Herbert L. Bonkovsky. (2022). Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias. Frontiers Media S.A..
Chicago Style (17th ed.) CitationChristopher D. Ma and Herbert L. Bonkovsky. Eslicarbazepine Acetate Is Porphyrogenic and Should Be Used with Caution in Patients with the Acute Hepatic Porphyrias. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationChristopher D. Ma and Herbert L. Bonkovsky. Eslicarbazepine Acetate Is Porphyrogenic and Should Be Used with Caution in Patients with the Acute Hepatic Porphyrias. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.